GT Healthcare Capital Partners is a venture capital firm headquartered in Hong Kong. It was founded in September 2015 by former pharmaceutical executive Alan Au. It makes early stage capital investments in healthcare technology companies. It has invested in the medical diagnostic, genetics, medical device, surgical robotics, and pharmaceutical sectors.
The firm frequently collaborates with Oxford, England based fund and accelerator Oxford Sciences Innovation, which targets investment in spin-outs from Oxford University technology, medical, life sciences, and mathematics departments.
Boundless Bio is a pioneer in understanding and treating the most intractable cancers. They have charted a new spatial map of the cancer genome within cancer cells and are harnessing their scientific founders' discoveries about "extrachromosomal DNA," or ecDNA, to drive a revolution in cancer therapeutics.